These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
80 related items for PubMed ID: 8597395
41. kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids. Gurwell JA, Duncan MJ, Maderspach K, Stiene-Martin A, Elde RP, Hauser KF. Brain Res; 1996 Oct 21; 737(1-2):175-87. PubMed ID: 8930364 [Abstract] [Full Text] [Related]
42. Effects of differentiation on neuropeptide-Y receptors and responses in rat pheochromocytoma cells. DiMaggio DA, Farah JM, Westfall TC. Endocrinology; 1994 Feb 21; 134(2):719-27. PubMed ID: 8299567 [Abstract] [Full Text] [Related]
43. Opioids suppress basal and nicotine-induced catecholamine secretion via a stabilizing effect on actin filaments. Dermitzaki E, Gravanis A, Venihaki M, Stournaras C, Margioris AN. Endocrinology; 2001 May 21; 142(5):2022-31. PubMed ID: 11316769 [Abstract] [Full Text] [Related]
44. Multiple opioid receptor systems in brain and spinal cord: Part I. Yaksh TL. Eur J Anaesthesiol; 1984 Jun 21; 1(2):171-99. PubMed ID: 6152613 [Abstract] [Full Text] [Related]
45. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine. Townsend D, Portoghese PS, Brown DR. J Pharmacol Exp Ther; 2004 Jan 21; 308(1):385-93. PubMed ID: 14569065 [Abstract] [Full Text] [Related]
46. Participation of GABA/benzodiazepine receptor system in the adrenal chromaffin cell function. Guidotti A, Hanbauer I. Adv Biochem Psychopharmacol; 1986 Jan 21; 42():165-72. PubMed ID: 3020895 [Abstract] [Full Text] [Related]
47. Ontogeny of O2 and CO2//H+ chemosensitivity in adrenal chromaffin cells: role of innervation. Salman S, Buttigieg J, Nurse CA. J Exp Biol; 2014 Mar 01; 217(Pt 5):673-81. PubMed ID: 24574383 [Abstract] [Full Text] [Related]
49. Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth. Hatzoglou A, Bakogeorgou E, Papakonstanti E, Stournaras C, Emmanouel DS, Castanas E. J Cell Biochem; 1996 Dec 15; 63(4):410-21. PubMed ID: 8978457 [Abstract] [Full Text] [Related]
50. Polyarthritis-associated changes in the opioid control of spinal CGRP release in the rat. Ballet S, Mauborgne A, Benoliel JJ, Bourgoin S, Hamon M, Cesselin F, Collin E. Brain Res; 1998 Jun 15; 796(1-2):198-208. PubMed ID: 9689470 [Abstract] [Full Text] [Related]
51. Maternal perinatal undernutrition has long-term consequences on morphology, function and gene expression of the adrenal medulla in the adult male rat. Laborie C, Molendi-Coste O, Breton C, Montel V, Vandenbulcke F, Grumolato L, Anouar Y, Vieau D. J Neuroendocrinol; 2011 Aug 15; 23(8):711-24. PubMed ID: 21564351 [Abstract] [Full Text] [Related]
52. Inhibition of calcium currents in rat colon sensory neurons by K- but not mu- or delta-opioids. Su X, Wachtel RE, Gebhart GF. J Neurophysiol; 1998 Dec 15; 80(6):3112-9. PubMed ID: 9862909 [Abstract] [Full Text] [Related]
53. Vasopressin receptors in human adrenal medulla and pheochromocytoma. Grazzini E, Breton C, Derick S, Andres M, Raufaste D, Rickwaert F, Boccara G, Colson P, Guérineau NC, Serradeil-le Gal C, Guillon G. J Clin Endocrinol Metab; 1999 Jun 15; 84(6):2195-203. PubMed ID: 10372731 [Abstract] [Full Text] [Related]
58. Effects of opioids on proliferation of mature and immature immune cells. Loh HH, Smith AP, Lee NM. Adv Exp Med Biol; 1993 Oct 15; 335():29-33. PubMed ID: 7901973 [No Abstract] [Full Text] [Related]
59. Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane. Oasa S, Sezgin E, Ma Y, Horne DA, Radmilović MD, Jovanović-Talisman T, Martin-Fardon R, Vukojević V, Terenius L. Transl Psychiatry; 2024 Nov 24; 14(1):477. PubMed ID: 39582064 [Abstract] [Full Text] [Related]
60. Workgroup report: incorporating in vitro alternative methods for developmental neurotoxicity into international hazard and risk assessment strategies. Coecke S, Goldberg AM, Allen S, Buzanska L, Calamandrei G, Crofton K, Hareng L, Hartung T, Knaut H, Honegger P, Jacobs M, Lein P, Li A, Mundy W, Owen D, Schneider S, Silbergeld E, Reum T, Trnovec T, Monnet-Tschudi F, Bal-Price A. Environ Health Perspect; 2007 Jun 24; 115(6):924-31. PubMed ID: 17589601 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]